FDA Approved: SOHONOS — Original Application (Ipsen Biopharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Sohonos (palovarotene) from Ipsen Biopharmaceuticals under an original application for the treatment of Fibrodysplasia ossificans progressiva.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrodysplasia Ossificans Progressiva

Drugs mentioned

• SOHONOS (PALOVAROTENE)

Snippet

ORIG AP for SOHONOS (PALOVAROTENE)